Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope
Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
AstraZeneca approached Gilead Sciences for a merger: Bloomberg report
Reportedly, AstraZeneca contacted Gilead last month but the latter is not interested in merging or selling to another big pharma…
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through…
COVID-19 drug research may drag on into July: Fujifilm
Researchers have only been able to get around 70 per cent of the patients needed for the trials
The COVID-19 effect on pharma packaging
Experts share insights on how COVID-19 is likely to alter trends in pharma packaging and determine its future progress
Combating COVID-19 with global standards
S Swaminathan, COO, GS1 India outlines why adoption of global standards within supply chains of drugs and PPE is critical to…
CSIR and AIM sign a LoI to foster innovation
The joint initiatives and collaboration will be implemented through the development of Work Plans
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage:…
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or…
Zydus Cadila get US FDA approval for Atazanavir capsules
It is used to treat HIV infection, in combination with other antiretrovirals
Kiran Mazumdar-Shaw awarded World Entrepreneur of the Year 2020 by EY
She is the first woman entrepreneur from India and third Indian to win this title in WEOY Award’s 20-year History
Anti-TNF therapies could treat patients with COVID-19-related ARDS
This would reduce COVID-19 mortality, as about 17 of COVID-19 patients develop ARDS, states GlobalData
By facilitating whole-genome sequencing we can help in taking swift treatment decisions
Ashish Kumar, Dubey, COO & Co-Founder, Redcliffe Life Sciences talks about how whole genome sequencing can help in predicting…
DoP issues brief guidelines for bulk drug parks, a detailed one to follow
It has also announced the details of a financial assistance programme, including grant-in-aid to three bulk drug parks with a…
Lonza appoints Pierre-Alain Ruffieux as new CEO
Ruffieux is currently Head of Global Pharma Technical Operations at Roche where he and his 12,000-strong team are responsible for…
Sun Pharma initiates Phase II clinical trial on AQCH as potential treatment for COVID-19
AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects…
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the…
Kappa Bioscience appoints Hidayat Ali as Head of Business Development, South Asia
Prior to joining Kappa, he held a position for SEKISUI Chemical, Japan where he oversaw growth of the synthetic amino acid for…
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi
Funding secured for Gavi’s next strategic period will help the Alliance reach an additional 300 million children in the world’s…
FDA approves Merck’s antibiotic drug to treat hospital-acquired bacterial pneumonia
The FDA is granting the approval to Merck for the drug, Recarbrio
Novavax gets US defense funding for its COVID-19 vaccine
The US-based company said the deal includes the delivery of 10 million doses of its COVID-19 vaccine - NVX‑CoV2373 - to the DoD…